Springer Nature
Browse
12885_2024_12263_MOESM1_ESM.docx (89.02 kB)

Additional file 1 of Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma

Download (89.02 kB)
journal contribution
posted on 2024-04-30, 04:00 authored by Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, Annette Lam, Tito Roccia, Jordan M. Schecter, Patricia Cost, Lida Pacaud, Abbey Poirier, Gabriel Tremblay, Tommy Lan, Satish Valluri, Shaji Kumar
Supplementary Material 1

Funding

This work was funded by Janssen Research and Development, LLC, and Legend Biotech USA Inc.

History

Usage metrics

    BMC Cancer

    Categories

    Keywords

    relapsed/refractory multiple myelomaSurrogate endpointProgression-free survivalOverall survivalInstrumental variable

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC